Biography:
Bachurin Sergey has completed his PhD and Dr. Sci. Degree in Moscow State University, Russia. In 1992 and in 1995 he had been working in the University San Francisco and in Taft’s University (USA). Since 2006 he is a director of the Institute of Physiologically Active Compounds, Russian Academy of Science in Chernogolovka, Russia, and the Head of Department of Medicinal and Biological Chemistry. He has published more than 220 papers in reputed journals and about 40 patents, and has been serving as an editorial board member of repute.
Title : The main trends in the developing novel therapeutics for alzheimer’s disease treatment